Developing A Gout Action Plan in Primary Care Setting in Singapore
Key facts
- Who runs it
- SingHealth Polyclinics
- Where
- Singapore1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 72 people, planned
- Started
- Aug 2025
- Expected to end
- Jul 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Gout action plan
- Record updated
- 11 July 2025
Who can take part
- Age
- 21 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Adults who are 21 years old and above
- Clinical diagnosis of gout as per ACE-EULAR 2015 criteria
- Had at least an episode of gout exacerbation within the last 1 year
- Able to speak and read English
- Singapore citizens or permanent residents
- Able to provide informed consent
- Currently still in clinical practice
- Manage gout in their clinical practice
Who cannot take part
- Mental disorders
- Cognitive impairment
- Known terminal illness
- Hearing and/ or speech impairments
- Pregnant
- Unable to provide informed consent; For healthcare professionals:
- Not involved in gout management in the practice
- No longer in clinical practice
Other criteria
- For patient participants:
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to develop a gout action plan in primary care setting in Singapore among adult patients with gout, and to learn if the gout action plan can improve gout control.
Read full original descriptionShow less
The main questions it aims to answer are:
* How do we develop a gout action plan in primary care setting in Singapore? * What is the feasibility and estimate effectiveness of the developed gout action plan? * Does gout action plan reduce frequency of gout flares in patients with gout?
Researchers will compare gout action plan to usual clinical care to see whether gout action plan helps in improving gout control.
Participants in intervention arm will be:
* given gout action plan and follow up for a course of 6 months * asked to keep track of their gout symptoms * follow up on the number of gout flares they have.
The 2 groups in the trial
- Control armNo study treatment, for comparison
Usual clinical care for this arm. No intervention delivered.
- Intervention armExisting treatment, for comparison
Patients in intervention arm will receive gout action plan on top of usual clinical care.
Treatment: Gout action plan
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 11 July 2025